texas oncology more breakthroughs. more victories
Due to facility issues Texas Oncology–Las Colinas will be closed the week of February 10–14 and Monday, February 17.  We apologize for any inconvenience. View More Important Notifications x

Tri Cao Le, M.D.

Tri Cao Le, M.D. Photo

Provider Type: Physician

Specialties:
Board Certifications:
  • Internal Medicine

Downloads

Education

  • Fellowship in Hematology and Medical Oncology 
    The University of Texas Southwestern Medical Center, Dallas, TX
  • Residency in Internal Medicine 
    The University of Texas Southwestern Medical Center, Dallas, TX
  • Medical Doctorate 
    Duke University, Durham, NC

Accolades & Memberships

Dr. Le is a member of the American Society of Hematology and the American Society of Clinical Oncology. He has authored and co-authored several publications in peer-reviewed journals and presented his work at numerous local and national conferences. His clinical excellence, commitment to teaching and mentorship, and leadership were recognized when he was selected as a chief resident and later, chief fellow at his training institutions.
  • The University of Texas Southwestern Medical Center, Chief Fellow, Dallas, TX (2020 – 2021)
  • Texas Society of Clinical Oncology Annual Conference, Outstanding Fellow Abstract (2019)
  • The University of Texas Southwestern Medical Center, Medical Student Clerkship Teaching Award for Faculty, Dallas, TX (2018)
  • Travel Grant for PRIME Oncology Young Investigator Forum (2018)
  • The University of Texas Southwestern Medical Center, Chief Resident, Dallas, TX (2017 – 2018)

Publications

  •  Covid-19 Associated Coagulopathy

    Feature Article in the University of Texas Southwestern Covid-19 Action Newsletter, 2020

  • Checkpoint Inhibitor Pneumonitis: Too Clinically Serious For Benefit?

    Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer, 2019

  • Improved Survival Outcomes for Kidney Cancer Patients with Brain Metastases

    Clinical Genitourinary Cancer, 2019

  • Newer-Generation EGFR Inhibitors in Lung Cancer: How Are They Best Used?

    Cancers, 2019

  • QTc Interval-Prolonging Medications Among Patients with Lung Cancer: Implications for Clinical Trial Eligibility and Clinical Care

    Clinical Lung Cancer, 2019

Show all Publications
  • Prevalence and Significance of Drug-Drug Interactions Among Patients With Lung Cancer

    Proceedings of the American Association for Cancer Research Annual Meeting 2019, 2019

  • Real World Outcomes of Nivolumab and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)

    American Society of Clinical Oncology, 2018

  • Improved Survival Rates in Kidney Cancer Patients with Brain Metastases Treated with Modern Multidisciplinary Approaches

    American Society of Clinical Oncology, 2018

  • Use of Qtc-prolonging Medications Among Patients With Lung Cancer: Implications for Clinical Trials and Standard Clinical Care

    American Society of Clinical Oncology 2018 Annual Meeting, 2018

  • The Enrollment Status of Patients with Brain Metastases in Metastatic Renal Cell Carcinoma: A Query of clinicaltrials.gov

    American Society of Clinical Oncology 2017 Annual Meeting, 2017

  • Anaplastic Lymphoma Kinase Alterations and Inhibition in Lung Cancer

    Seminars in Cancer Biology, 2017

  • Upper Lip Metastasis of Sarcomatoid Carcinoma of the Lung - an Unusual Site of Disease: a Case Report

    Journal of Medical Case Reports, 2017

  • Histologic Transformation of EGFR Mutant Lung Adenocarcinoma Without Wxposure to EGFR Inhibition

    Lung Cancer, 2017

  • Incidence of Brain Metastases in Metastatic Renal Cell Carcinoma in the Era of Targeted Therapies

    ASCO Annual Meeting, 2016

Other Information

Dr. Le is married with one child and a dog. He and his wife enjoy traveling, cooking, and exploring interesting restaurants.